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feature for colleagues to share practical interventions, innova-
tions and novelties that have proved useful in the management
of patients in the prehospital environment or Emergency Cen-
tre. You can let Ujuzi know about your practical ideas by
emailing practicalpearl@afjem.com.Ketamine procedural sedation in low resource settings
Procedural sedation and analgesia (PSA) is a core competency
in emergency medicine (EM). As EM develops in low resource
settings, it is incumbent upon the emergency medicine commu-
nity to ensure that evidence based trainings are developed to
enable providers in these setting to safely provide PSA. This
will avert unnecessary delays and patient suffering from inad-
equate pain management and sedation during painful
procedures.
In addition to lack of providers trained in PSA, the other
usual limiting factors in low resource settings are lack of prop-
er monitoring equipment and supplemental oxygen.1 This
makes ketamine the ideal choice for PSA in these settings.
Ketamine is a dissociative anesthetic that has both amnestic
and analgesic properties. Its effects do not ﬁt into the typical* Tel.: +1 860 986 1723; fax: +1 508 334 7411.
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tered properly, ketamine is associated with exceedingly low
risk of respiratory depression or hemodynamic instability.
Additionally, patients under ketamine anesthesia maintain
protective airway reﬂexes.
Ketamine has a long history of extensive use in low re-
source settings.1–3 However, ketamine can cause adverse events
if used incorrectly or administered to an improperly selected
patient. Practical pearls for ketamine use can be divided into
patient selection, administration and rescue from adverse
events.
Patient selection:
1. In terms of severity, the major adverse event is laryngo-
spasm (incidence 0.3%).4 Patients with active upper respira-
tory tract infections may be at increased risk, although the
evidence for this is not strong.5 Given the difﬁculty of man-
aging prolonged laryngospasm in resource limited settings,
providers without advanced airway expertise should
strongly consider alternatives to ketamine in patients with
upper respiratory tract infections.
2. Concerns about ketamine increasing intracranial pressure
(ICP) are likely overstated and some evidence exists that ket-
amine actually lowers ICP.4,6 We do not restrict ketamine use
in patients with possible intracranial pathology in our setting.
3. In some settings there was hesitancy to administer ketamine
to adults for fear of unacceptably high rates of emergence
reaction. This has also been disproven.2 Emergence reac-
tion is a risk with ketamine, but the overall beneﬁts of
the drug usually far outweigh these risks.
4. There is an increased rate of adverse events from any anes-
thetic agent in very young patients (i.e. less than 3 months).
However, if a small child needs a painful procedure andn and hosting by Elsevier B.V. All rights reserved.
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may proceed with extra caution after explaining the risks
to the parents.
Administration
1. Intravenous: The starting dose should be 1.5 mg/kg. If
there is inadequate sedation after 30 s, another 0.5–
1.0 mg/kg should be administered.
2. Intramuscular: The starting dose should be 5 mg/kg and it
will take approximately 4 min to take effect.
3. While some providers choose to administer supplemental
oxygen during ketamine PSA, most experts agree it is not
necessary. We do give concentrated oxygen if available,
but concur it is not mandatory in cases where the patient
has a normal saturation before sedation.
4. Ketamine can cause respiratory depression if given in a
rapid bolus. Therefore, slowly administer the dose over
45–60 s.
5. Some hospitals only stock ketamine in concentrations of
50 mg/mL. In children this concentration is hard to admin-
ister slowly. We recommend diluting the ketamine with
sterile water or normal saline to bring the volume to be
administered up to 2 or 5 mL for ease of administration.
6. There is no beneﬁt to routinely administering anticholiner-
gic agents with ketamine, as it has not been shown to
decrease the rate of laryngospasm or other respiratory
adverse events.4 Additionally, atropine can compound the
tachycardia seen with ketamine alone and can cause
arrhythmias.
7. In children, evidence is clear that prophylactic benzodiaze-
pines should not be given to prevent emergence reactions.7
Some controversy still exists regarding this practice in
adults.8 Given the respiratory depressive effects of benzodi-
azepine and limited monitoring equipment in low resource
settings, we do not recommend routine administration of
benzodiazepines with ketamine.
Rescue from adverse events
1. The main adverse event of concern with ketamine adminis-
tration is laryngospasm. Providers administering ketamine
should be able to recognize and competently manage laryn-
gospasm. The main rescue technique is bag valve mask
(BVM) ventilation. Additionally, the laryngospasm ‘‘point’’
has been described and can be used in addition to BVM to
rescue patients with this adverse event. This maneuver is
accomplished by placing ﬁrm pressure, directed inward
toward the base of the skull, on a point behind the pinna
bounded by the mandibular ramus anteriorly and the mas-
toid posteriorly.9
2. Although ketamine does not decrease respiratory drive,
desaturation can occur due to patient positioning. Provid-
ers should be familiar with proper patient position to main-
tain and open the airway.3. If the patient’s attendants will be present or within close
proximity during the procedure, they should be forewarned
that the patient will experience nystagmus, may yell, talk,
or move while sedated, but is not experiencing pain and will
not remember the procedure.
4. A portion of patients (up to 10–20% in some reports) will
experience hypersalivation. The airway can be cleared with
gauze and by turning the head to the side if suction is
unavailable. In more extreme cases (which will be rare),
atropine or other anticholinergic agent can be given if this
complication occurs.
5. If an unpleasant emergence reaction occurs, a standard
dose of any benzodiazepine can be administered. However,
this scenario will be rare if the patient is recovered in a quiet
area with an attendant at the bedside.
Ketamine has a long history of safe use for PSA in a variety of
settings. Given the low risk of major adverse events, its hemo-
dynamic stability and lack of respiratory depressive effects,
ketamine is an ideal agent for PSA in low resource settings.
As ‘‘task shifting’’ is employed to increase access to care in
these settings, careful thought should be giving to training
additional providers in ketamine administration. Certainly,
as the specialty of emergency medicine develops in these coun-
tries, training in the use of ketamine should be considered a
core competency.
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